secwatch.observer — SEC 8-K summary
======================================

Issuer:     Invivyd, Inc. (IVVD)
CIK:        0001832038
Form:       8-K
Filed at:   2022-06-21T23:59:59+00:00
Accession:  0001193125-22-177777
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Anand Shah resigns from board of Adagio Therapeutics, effective June 22, 2022
--------------------------------------------------------------------------------

- Anand Shah, M.D. resigned from the board of directors and all committees.
- Resignation effective immediately after the 2022 annual meeting on June 22, 2022.
- No reason for the departure was disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832038/000119312522177777/0001193125-22-177777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832038/000119312522177777/d330381d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-177777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer